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a b s t r a c t
To test the hypothesis that embryogenesis depends upon α-tocopherol (E) to protect embryo
polyunsaturated fatty acids (PUFAs) from lipid peroxidation, new methodologies were applied to
measure α-tocopherol and fatty acids in extracts from saponiﬁed zebraﬁsh embryos. A solid phase
extraction method was developed to separate the analyte classes, using a mixed mode cartridge (reverse
phase, π–π bonding, strong anion exchange), then α-tocopherol and cholesterol were measured using
standard techniques, while the fatty acids were quantitated using a novel, reverse phase liquid
chromatography–mass spectrometry (LC–MS) approach. We also determined if α-tocopherol status
alters embryonic lipid peroxidation products by analyzing 24 different oxidized products of arachidonic
or docosahexaenoic (DHA) acids in embryos using LC with hybrid quadrupole-time of ﬂight MS. Adult
zebraﬁsh were fed E or Eþ diets for 4 months, and then were spawned to obtain E and Eþ embryos.
Between 24 and 72 hours post-fertilization (hpf), arachidonic acid decreased 3-times faster in E (21 pg/h)
compared with Eþ embryos (7 pg/h, Po0.0001), while both α-tocopherol and DHA concentrations
decreased only in E embryos. At 36 hpf, E embryos contained double the 5-hydroxy-eicosatetraenoic
acids and 7-hydroxy-DHA concentrations, while other hydroxy-lipids remained unchanged. Vitamin E
deﬁciency during embryogenesis depleted DHA and arachidonic acid, and increased hydroxy-fatty acids
derived from these PUFA, suggesting that α-tocopherol is necessary to protect these critical fatty acids.
& 2013 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
Traditional methods of measuring of long chain polyunsaturated
fatty acids (PUFAs) by gas chromatography require derivatization and
result in long retention times and broad peak shapes [1,2]. Liquid
chromatography with mass spectrometry (LC–MS) using a reverse
phase column has the advantage of reversing the order of reten-
tion such that peaks of interest, such as docosahexaenoic acid
(DHA, 22:6 ω-3), emerge early in the chromatography. Additional
advantages include shortened run times, separation does not
require sample derivatization, and LCMS allows absolute quantita-
tion by use of internal standards that co-elute with the fatty acids
of interest because they are identical to the fatty acid with the
exception of the stable-isotope label. These labeled fatty acids can
be added prior to extraction of the sample and thus provide a measure
of recovery through the multiple steps necessary to prepare the
sample. We sought to develop such methods to evaluate the effect
of vitamin E deﬁciency during embryogenesis in zebraﬁsh.
Previously, we observed that vitamin E deﬁcient zebraﬁsh
embryos develop morphologic abnormalities by 48 hours post-
fertilization (hpf) [3]. More severe abnormalities were observed in
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α-tocopherol transfer protein knockdown zebraﬁsh embryos,
which by 15 hpf have a head and/or brain malformation [4].
Docosahexaenoic acid (DHA, 22:6 ω-3) is a polyunsaturated fatty
acid (PUFA) required for proper embryonic neurodevelopment.
DHA is highly enriched in the human central nervous system
(CNS), comprising upwards of 50% of CNS PUFA content [5]. Rapid
accretion of DHA within the CNS occurs during the last trimester
of pregnancy in humans [6] and coincides with a time of maximal
neurogenesis and synaptogenesis [7]. Studies in rats and monkeys
have shown that maternal ω-3 PUFA deﬁciency leads to impaired
fetal neurogenesis [8,9] and neuronal migration [10], reduced
visual acuity [11,12], altered dopaminergic regulatory protein
composition [13] and neuronal phospholipid composition [14]
(and presumably signaling [15]). Adverse developmental outcomes
caused by DHA inadequacy persist even after repletion with DHA
[16,17], demonstrating long-lasting effects of embryonic DHA
deﬁciency regardless of later restitution with an adequate diet.
Notably, the dietary essential fatty acids, linoleic acid (18:2 ω-6)
and α-linolenic acid (18:3 ω-3), comprise less than 1% of neural
PUFAs [18]. The fetal liver and brain are capable of synthesizing
DHA from α-linolenic [19,20]; however, this synthetic capacity
decreases over time [21] and in adult humans is limited such that
less than 5% of ingested α-linolenic is converted to DHA [22,23].
Additionally, greater amounts of DHA are accumulated within the
developing brain when preformed DHA is supplied to the devel-
oping fetus [24,25]. Studies evaluating the efﬁcacy of α-linolenic
supplementation to preterm infants demonstrate that endogenous
DHA synthesis cannot match in utero accretion rates of preformed
DHA [26]. Indeed, the placenta preferentially transfers DHA over
other PUFAs to the developing fetus [27,28].
Arachidonic acid (20:4 ω-6) is the most abundant ω-6 neuronal
fatty acid throughout gestation and postnatal development [6].
It is a component of cellular phospholipids and functions as a
precursor for lipid secondary messengers involved in numerous
cell-signaling pathways. An appropriate balance between DHA and
arachidonic acid is required during neonatal development, as
infant formula supplemented with DHA, but lacking arachidonic
acid, impaired infant growth [29]. Indeed, higher infant arachido-
nic acid concentrations are positively correlated with infant birth
weight and length [30]. Conversely, arachidonic acid inadequacy is
associated with delayed postnatal development and reduced
growth [31].
In 1922, α-tocopherol (vitamin E) was discovered because rats
fed rancid fat failed to carry their offspring to term [32]. Unlike
other vitamins, α-tocopherol's speciﬁc biologic function, and the
mechanism mediating its requirement for reproduction, remains
unknown. α-Tocopherol is a lipid soluble antioxidant and co-
localizes with PUFA-enriched phospholipid domains of the cell
membrane [33], which are highly susceptible to peroxidation.
Indeed, α-tocopherol requirements increase in parallel with diet-
ary PUFA consumption or with an increasing index of fatty acid
unsaturation [34]. Studies in experimental animals have demon-
strated the importance of α-tocopherol in protecting PUFAs: adult
zebraﬁsh fed a vitamin E deﬁcient diet have reduced visceral percen-
tages of total ω-6 and ω-3 PUFAs [35] and feeding ﬁsh oil to rat
mothers decreased fetal brain α-tocopherol concentrations [31].
DHA and arachidonic acid are enzymatically oxidized to a large
class of signaling molecules with a wide array of functions [36].
Oxidation of arachidonic acid gives rise to hydroxy-eicosatetraenoic
acids (HETEs) and the eicosanoids, a class of lipids that encompass
the prostaglandins, prostacyclins, thromboxanes, leuokotrienes,
lipoxins, and isoprostanes. Similarly, DHA oxidation gives rise to
the docosanoids, which include the resolvins (D-series), neuro-
protectins, and maresins, as well as intermediary monohydroxy
lipids, termed HDHAs. Oxidation of DHA and arachidonic acid to
these signaling molecules can occur both through enzymatic
peroxidation or non-enzymatic radical-mediated peroxidation
[37,38]. The three known enzymatic pathways that act upon PUFAs
include the cyclooxygenase (COX), lipoxygenase (LOX), and cyto-
chrome P450 (CYP450) pathways.
We hypothesize that embryonic development depends upon
sufﬁcient DHA, arachidonic acid and speciﬁc oxidation products of
DHA and arachidonic acid, as well as sufﬁcient α-tocopherol to
protect the embryo from lipid peroxidation products. To test this
hypothesis we induced vitamin E deﬁciency in zebraﬁsh embryos
by dietary manipulations in the parents. We developed a highly
sensitive, novel method using solid phase extraction, liquid chro-
matography and mass spectrometry to quantify α-tocopherol,
cholesterol and fatty acids in these embryos. Additionally, 24
different oxidized products of arachidonic or DHA acids were
analyzed using ultra high-performance liquid chromatography
coupled with hybrid quadrupole-time of ﬂight mass spectrometry.
Methods
Ethics statement
This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All protocols were
approved by the Institutional Animal Care and Use Committee of
Oregon State University (ACUP Number: 4344). All ﬁsh were
euthanized by tricaine (MS 222, Argent Chemical Laboratories,
Inc., Redmond, WA) overdose prior to sampling, and every effort
was made to minimize suffering.
Fish husbandry
Tropical 5D strain zebraﬁsh were housed in the Sinnhuber Aquatic
Research Laboratory at Oregon State University and studied in
accordance with protocols approved by the Institutional Animal Care
and Use Committee. Adult zebraﬁsh were kept under standard
laboratory conditions at 28.5 1C with a 14 h light/10 h dark cycle.
Embryos were obtained through natural group spawning, collected,
and kept in standard ﬁsh water. Embryos used for analysis, described
below, were euthanized by an overdose of tricaine.
Feeding study
Beginning at 50 days post-fertilization and up to 6 months,
zebraﬁsh were fed either a deﬁned diet (described below) or a
conventional zebraﬁsh diet (hereafter referred to as “Lab”), as
previously described [35]. The lab diet is a mix of commercially
available foods with undeﬁned ingredients, thus it contains large
amounts of ﬁsh oil and ﬁshmeal.
The deﬁned diets were prepared in 300-g batches containing
143716mg ascorbic acid/kg (as StayC [500mg/kg], Argent Chemical
Laboratories Inc., Redmond, WA) without (E) or with added α-
tocopherol (Eþ , 500 mg RRR-α-tocopheryl acetate/kg diet, ADM,
Decatur, IL). Measured α-tocopherol concentrations in the E and
Eþ diets were 1.670.1 and 334712mg/kg, respectively. Diets were
stored at 20 1C until fed to the zebraﬁsh. The fatty acid compositions
of the deﬁned diets were described previously [35] and consisted
primarily of palmitic, stearic, oleic, α-linolenic, and linoleic acids. The
deﬁned diets did not contain any PUFAwith carbon chains longer than
α-linolenic or linoleic acids.
Embryos from adult zebraﬁsh fed the lab diet hereafter are
called “Lab embryos”, while the embryos from adult zebraﬁsh fed
the E or Eþ diets are called “E embryos or Eþ embryos”. Note
that the embryos themselves were not fed these diets, they were
obtained from ﬁsh fed the diets a minimum of 4 months. The growth
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curves and α-tocopherol depletion curve for the adult ﬁsh and the
embryo morphology were described previously [3].
Sample preparation for α-tocopherol, fatty acid, and cholesterol
analyses
At 24 hpf, embryos (n¼10 embryos per condition) were
collected in 1.6 mL centrifuge tubes, excess water removed, and
snap-frozen in liquid nitrogen and stored at 80 1C until analyzed.
Embryos were added to 10 mL screw top, round-bottom, glass
tubes with teﬂon-lined caps containing 2 mL 1% ascorbic acid in
ethanol (w/v) and 1 mL Milli-Q water (Millipore, Billerica, MA).
The following deuterium-labeled (d) internal standards were
obtained from Cayman Chemical (Ann Harbor, MI): α-linolenic-d14,
eicosapentaenoic acid-d5, DHA-d5, linoleic acid-d4, and arachido-
nic acid-d8. These were diluted in ethanol, and then added in
amounts equivalent to the expected normal endogenous levels of
respective fatty acids. Delta-tocotrienol (δT3) was added as an
internal standard for α-tocopherol. Following addition of saturated
KOH (300 mL), tubes were gently mixed, ﬂushed with argon, and
then placed in a water bath at 65 1C for 30 min. After cooling to
room temperature, the samples were adjusted to a pH of 7.570.1
with 3 N HCl for solid phase extraction.
Solid phase extraction and separation of lipids
We developed a solid phase extraction method to separate the
three analyte classes, using a mixed mode cartridge (reverse
phase, π–π bonding, strong anion exchange, according to the
manufacturer, Phenomenex, Torrance, CA). Strata-X-A 33 mm Poly-
meric Strong Anion Exchange cartridges (200 mg/3 mL, Phenom-
enex), loaded on a Zymark Rapid Trace SPE robot (Caliper Life
Sciences, Hopkinton, MA), were conditioned with 3 mL methanol
followed by 3 mL Milli-Q water. Saponiﬁed samples (described
above) with added internal standards were then loaded onto the
prepared cartridges. The elution strategy was as follows. Choles-
terol, bound to the stationary phase by hydrophobic interactions, was
eluted from the cartridges using 4 mL methanol. Using the robots,
cartridges were partially dried with three consecutive “washes” of
6 mL air, and then α-tocopherol was eluted from the cartridge with
4 mL acetonitrile to disrupt π–π bonding. Finally, PUFAs were eluted
from the cartridge with 4 mL formic acid in methanol–acetonitrile
(5:47.5:47.5, v/v/v). The acidiﬁed solvent was used to overcome ionic
bonding; the inclusion of acetonitrile in the latter mixture was needed
to overcome the π–π bonding of the more highly unsaturated PUFAs.
Extracts were dried under nitrogen, resuspended in the appropriate
solvent, and then analyzed as described in the appropriate sections
below. The cholesterol-containing extract was resuspended in 200 mL
1X Amplex Red Cholesterol Assay reaction buffer (Life Technologies,
Carlsbad, CA), the α-tocopherol-containing extract was resuspended in
50:50 (v/v) methanol–ethanol, and the PUFA-containing extract was
resuspended in methanol containing 0.1% (v/v) formic acid.
Cholesterol analyses
Cholesterol was analyzed using the Amplex Red Cholesterol
Assay Kit (Life Technologies, Carlsbad, CA) according to the
manufacturer's instructions. Speciﬁcally, cholesterol concentra-
tions were determined ﬂuorometrically using a SpectraMax
Gemini XS microplate spectroﬂuorometer (Molecular Devices,
Silicon Valley, CA) with an excitation wavelength of 545 nm and
an emission wavelength of 590 nm and quantitated using authen-
tic cholesterol standards. Cholesterol concentrations were esti-
mated based on the various dilution factors used.
α-Tocopherol analyses
α-Tocopherol and δT3 concentrations were analyzed by high
performance liquid chromatography (HPLC) with electrochemical
detection, as previously described [39]. Brieﬂy, the samples or
standards were injected onto the HPLC system, the mobile phase
consisted of 0.1% (w/v) lithium perchlorate in 98:2 (v/v) methanol:
water, the analytes were detected using an electrochemical detec-
tor. α-Tocopherol concentrations were calculated from the peak
area ratios of α-tocopherol to δT3 using authentic compounds to
generate a standard curve.
Free fatty acids via LC–MS
HPLC was performed on a Shimadzu Prominence system (DGU-
20A3 degasser, two LC-20AD pumps, CMB-20A control module, and
SIL-20AC HT autosampler) coupled through an electrospray ionization
source to a single quadrupole MS (LC–MS 2010A Shimadzu, Columbia,
MD) operated in negative single ion monitoring mode (Table 1 for
analyte m/z ratios). The mass spectrometer acquisition time was set at
0.5 s, the detector voltage at 1.5 kV, the curved desolvation line
temperature at 230 1C, the block temperature at 200 1C, and the
nitrogen nebulizing gas at 2.5 mL/min. Drying gas pressure was set to
0.1 MPa. Chromatographic separations were carried out on an Ascentis
Express C8 column (15 cm2.1 mm2.7 mm, Supelco, Bellefonte, PA)
with matching guard column. Mobile phases consisted of 0.05% (v/v)
acetic acid in (A) Milli-Q water and in (B) methanol with a total ﬂow of
0.2 mL/min. The elution gradient was 0 min, 80% B; 12 min, 85% B;
15 min, 85% B; 18 min, 100% B; 22min, 100% B; 22 min, 80% B. The
injection volume was 1 mL. The C8 LC/MS column (Ascentis Express),
which is a superﬁcially porous C8 column, was used with the
optimized solvent gradient to resolve isobaric positional isomers of
free fatty acids, which was conﬁrmed using authentic standards. For
example, gamma-linolenic acid (18:3 ω-6) was resolved from
α-linolenic (18:3 ω-3), enabling accurate quantitation of the latter.
Analyte concentrations were calculated from the peak area ratios of
authentic compounds (obtained from Cayman Chemicals) to internal
standards.
Table 1
PUFAs and hydroxy-PUFAs: abbreviations and detection characteristics.
Analyte Abbreviation m/z, [M–H]
Fatty acids
Linoleic acid (18:2 ω-6) linoleic acid 279.2
Linoleic acid-d4 linoleic acid-d4 283.2
Arachidonic acid (20:4 ω-6) arachidonic acid 303.2
Arachidonic acid-d8 arachidonic acid-d8 311.2
α-Linolenic acid (18:3 ω-3) α-linolenic 277.2
α-Linolenic acid-d14 α-linolenic-d14 291.2
Eicosapentaenoic acid (20:5 ω-3) eicosapentaenoic 301.2
Eicosapentaenoic acid-d5 eicosapentaenoic-d5 306.2
Docosahexaenoic acid (22:6 ω-3) DHA 327.2
Docosahexaenoic acid-d5 DHA-d5 332.2
Hydroxy-fatty acids Abbreviation m/z-m/z (XIC)
Derived from DHA
7-hydroxy-4Z,8E,10Z,13Z,16Z,19Z – DHA 7-HDHA 343.2141.0
10-hydroxy-4Z,7Z,11E,13Z,16Z,19Z – DHA 10-HDHA 343.2153.0
14-hydroxy-4Z,7Z,10Z,12E,16Z,19Z – DHA 14-HDHA 343.2205.1
17-hydroxy-4Z,7Z,10Z,13Z,15E,19Z – DHA 17-HDHA 343.2201.1
Derived from arachidonic acid
(eicosatetraenoic acid; ETE)
5-hydroxy-6E,8Z,11Z,14Z – ETE 5-HETE 319.2115.0
12-hydroxy-5Z,8Z,10E,14Z – ETE 12-HETE 319.2179.1
20-HETE-d6 325.2281.2
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Precision and recovery experiments
Lab embryos (n¼300) from zebraﬁsh under our standard condi-
tions were collected at 5 hpf, homogenized in 3 mL 1% ascorbic acid
(w/v) in ethanol, and stored at 80 1C until analyzed. Six replicate
aliquots (100 mL) were extracted and analyzed for PUFAs and α-
tocopherol (described above) on three different days. Within-day,
between-day, and total imprecision were calculated according to the
method of Krouwer and Rabinowitz [40,41]. Recovery was calculated
relative to a methanol sample, spiked with an equivalent concentra-
tion of internal standards as samples used for precision experiments,
analyzed without prior extraction on three different days.
Analysis of PUFAs by LC–MS
We developed novel methods for the analysis of PUFAs with
optimized HPLC gradient conditions. Total run time was 30 min,
which includes the 8 min required for column re-equilibration
between runs. Typical retention times were linoleic acid 10.9 min,
arachidonic acid 10.8 min, α-linolenic 8.8 min, eicosapentaenoic
acid 8.7 min, and DHA 10.5 min. Calibration curves relating the
amount of analyte injected on column to the area ratio of each
PUFA to its respective deuterated analog showed linear responses
in the following ranges (ng injected on column): linoleic acid,
1–125 ng; arachidonic acid, 1–160 ng; α-linolenic, 0.5–25 ng;
eicosapentaenoic, 0.4–50 ng; and DHA, 0.5–200 ng. The lower
limit of detection for each PUFA was approximately 0.1 ng injected
on column, while the lower limit of quantitation was approxi-
mately 0.2 ng injected on column.
Oxidized lipid extraction and UPLC-MS/MS
At 24 or 36 hpf, embryos (n¼200, or n¼100, respectively, as
indicated in ﬁgure legends) were collected in 1.6 mL tubes, water
removed, and snap-frozen in liquid nitrogen. All samples were
stored at 80 1C until analysis. Embryos were transferred to 10 mL
screw-top, round bottom, glass tubes with teﬂon-lined caps,
homogenized in 3 mL ice-cold 66% LC–MS grade methanol con-
taining internal standard 20-HETE-d6 (20-hydroxy-5Z,8Z,11Z,14Z-
eicosatetraenoic acid-d6, m/z 325.2-281.2, Cayman Chemical),
and placed at 80 1C for 1 h. The embryo homogenate was then
transferred to 1.6 mL polypropylene tubes and centrifuged at
3000g at 4 1C for 15 min. The supernatant was collected and dried
under nitrogen. Samples were resuspended in 100 mL methanol
with 0.1% formic acid (v/v) and transferred to injection vials. Ultra
high-performance liquid chromatography was performed using a
4 mL injection onto a Shimadzu Nexera system (Shimadzu, Colum-
bia, MD) coupled to a hybrid quadrupole-time of ﬂight MS
(TripleTOF™ 5600, AB SCIEX). Chromatographic separations were
carried out on a Brownlee Analytical DB AQ C18 column
(1002.1 mm, 1.9 mm, PerkinElmer). The ﬂow rate was 0.35 mL/min
and mobile phases consisted of water (A) and acetonitrile (B), both
with 0.1% formic acid. The elution gradient was 0 min, 35% B; 2.5 min,
50% B; 7 min, 64.4% B; 9 min, 100% B; 12 min, 100% B; 12.5 min, 35% B;
and 13.5 min, 35% B. Column temperature was held at 40 1C. Mass
spectrometry was performed using an electrospray ionization source.
The instrument was operated in high-resolution product ion mode
and negative ion polarity. Product ion accumulation timewas 0.12 s for
each parent ion; collision energies were between 15 and 25 V.
Scan range for each product ion experiment was m/z 40–450. Ion
source gas 1 and 2 and curtain gas (all nitrogen) were set at 50, 40,
and 25, respectively. The source temperature was set at 500 1C and
IonSpray voltage at 5.5 kV. Two-min auto calibrations were per-
formed hourly. In preliminary experiments of lab embryos (data not
shown), we found that only 5-HETE, 12-HETE, 7-HDHA, 10-HDHA,
14-HDHA, and 17-HDHA were detectable in the embryo extracts.
The m/z ratios of fragments were used for identiﬁcation in post-
acquisition ﬁltering (Table 1; Figs. 1 and 2). Standard curves of each of
these lipids at concentrations of 1000, 100, 10 μg/L were generated.
Area counts were corrected for recovery of the internal standard and
concentrations were calculated using standard curves generated from
the authentic compounds, which were injected on three separate
occasions during the sample analysis.
Statistics
Statistical analysis was performed using GraphPad Prism
(GraphPad Software, San Diego, CA). Time-course E and Eþ
embryo PUFAs were analyzed using two-way ANOVA; time course
for each PUFA was analyzed by repeated measures one-way
ANOVA. Time-course PUFAs in lab embryos were analyzed sepa-
rately using a two-way ANOVA. Multiple paired comparisons were
carried out using a Tukey test. E and Eþ embryo hydroxy-PUFA
data were analyzed using a t-test. Data were log-transformed
when unequal variances were observed between groups, as con-
ﬁrmed by Bartlett's test for equal variances. When hydroxy-lipids
were below levels of detection, Fisher's exact test was used to
assess statistical signiﬁcance.
Results
Fatty acid, cholesterol and α-tocopherol precision and recovery
To test precision, six aliquots of the embryo homogenate
were analyzed in three separate batches over a 2-week time
Fig. 1. Structures of hydroxy-lipids. Shown are the structures of 5-HETE, 12-HETE,
7-HDHA, 10-HDHA, 14-HDHA, and 17-HDHA.
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period. The within-day and between-day variance did not exceed
5% for any of the PUFA or α-tocopherol concentrations (Table 2).
Analyte recovery exceeded 70% for each PUFA, but was 50%–60%
for α-tocopherol. Cholesterol recovery was not determined since
we did not have labeled-cholesterol or a validated method for
labeled cholesterol measurements using LC/MS; additionally this
Fig. 2. Chromatograms and fragmentation patterns of hydroxy-lipids. Shown in A, B, C are the chromatograms (left panel) and fragmentation patterns (right panel) of
authentic samples of 5-HETE, 12-HETE, 20-HETE-d6, respectively. Shown in D are the chromatograms of 7-HDHA, 10-HDHA, 14-HDHA, and 17-HDHA, as indicated. These
hydroxy fatty acids were detectable in extracts of zebraﬁsh embryos at 24 hpf. Table 1 shows the mass spectrometry detection characteristics (m/z ratios).
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measure was not a focus of our experiments. It should be noted
that all values reported have been corrected using the added
internal standards for PUFAs and tocopherol.
Analysis of PUFAs in zebraﬁsh embryos fed a laboratory diet
We established a time course of concentrations of unsaturated
and polyunsaturated fatty acids of interest (linoleic acid, arachi-
donic acid, α-linolenic acid, eicosapentaenoic acid, DHA) during
normal zebraﬁsh embryonic development. Zebraﬁsh (fed a com-
mercial laboratory diet) were spawned and embryos harvested at
3, 24, 48 and 72 hpf. Embryo fatty acid concentrations did not
change signiﬁcantly between 3 and 24 hpf (Fig. 3), suggesting that
the fatty acids present were those deposited in the eggs by the
zebraﬁsh mother. Notably, the DHA concentrations were about
20-fold more than the other fatty acids measured, reﬂecting the
abundant ﬁsh oil and ﬁshmeal present in the diets fed to the adult
zebraﬁsh. Between 24 and 72 hpf, all PUFA fatty acids decreased
when expressed per embryo (Fig. 3). The rates of decrease were
greatest for DHA (65 pg/h), followed by linoleic acid (12 pg/h) and
eicosapentaenoic (7 pg/h), while α-linolenic and arachidonic acid
decreased similarly and more slowly (2 pg/h).
α-Tocopherol deﬁciency alters PUFA concentrations and utilization
during embryonic development
We have reported that the E embryos suffered increased
morbidity and mortality as a result of inadequate α-tocopherol
status [3]. We hypothesize that α-tocopherol is required during
embryonic development speciﬁcally to protect DHA and arachi-
donic acid and that these critical PUFA are depleted during
α-tocopherol deﬁciency. PUFA concentrations were measured in
E and Eþ embryos from 3 to 72 h. It should be noted that the
deﬁned diets contain no fatty acids longer than C18; thus, initial
concentrations of arachidonic acid and DHA found in eggs are derived
from adult zebraﬁsh synthesis of arachidonic acid and DHA from
linoleic acid and α-linolenic, respectively. This requirement is not the
case for zebraﬁsh fed the lab diet, which contains ﬁsh oil, and thus
the PUFA concentrations observed in embryos are not directly
comparable between diets.
E embryos contained 40-fold less α-tocopherol compared
with Eþ embryos (Po0.0001, Fig. 4F). α-Tocopherol concentra-
tions in the embryos did not change between 3 and 24 hpf and did
not change in Eþ embryos up to 72 hpf. However, α-tocopherol
concentrations in E embryos decreased at 11 pmol/h between 24
and 72 hpf.
α-Tocopherol status altered the embryonic PUFA concentra-
tions, as well as the magnitude of change in PUFAs during
development (Fig. 4). At 3 hpf, E embryos on average contained
0.4 ng more linoleic acid (Fig. 4A, P¼0.0002) and 0.7 ng more
arachidonic acid (Fig. 4B, Po0.0001) compared with the Eþ
embryos. In E embryos, linoleic acid decreased at 22 pg/h
(Fig. 4A), and arachidonic acid decreased at 21 pg/h (Fig. 3B), while
in Eþ embryos the rates of decrease in these omega-6 fatty acid
concentrations were slower (linoleic acid 16 pg/h, P¼0.0051 and
arachidonic acid 7 pg/h, Po0.0001). With regard to omega-3 fatty
acids, no differences in α-linolenic concentrations at 3 hpf or
throughout development were observed between E and Eþ
embryos, although concentrations in both groups decreased at
0.7 pg/h (Fig. 4C). However, stark differences were noted between
E and Eþ embryos in eicosapentaenoic and DHA concentrations.
Eþ embryos contained double the eicosapentaenoic concentra-
tions of E embryos throughout the 72 h of the study (Fig. 4E).
Eicosapentaenoic levels decreased in both groups with the
decrease in Eþ embryos occurring at a greater rate (0.4 pg/h)
Table 2
Precision of PUFA, α-tocopherol, and cholesterol measurements in 5 h post-fertilization zebraﬁsh embryos.
Mean7SDa Within-day CVb (%) Between-day CV (%) Total CV (%) % Recovery
Linoleic acid ng/embryo 2.170.1 3 0 3 7772
Arachidonic acid ng/embryo 0.770.0 2.8 2.4 3.7 7772
α-Linolenic acid ng/embryo 0.270.0 4.5 1.8 4.9 7573
Eicosapentaenoic acid ng/embryo 1.370.1 3.4 0 3.4 8275
DHA ng/embryo 21.970.8 3.1 1.4 3.4 8073
α-Tocopherol pmol/embryo 91.475.7 3.9 3.1 5 5774
Cholesterol nmol/embryo 10.372.5 24.9 0 24.9 NDc
a Mean7SD of six replicate aliquots (100 mL) of zebraﬁsh embryos extracted and analyzed on three different days. Embryos (5 hours post-fertilization) were from adults
fed standard laboratory diets.
b CV¼ (SD/mean)100.
c Not determined.
Fig. 3. PUFA concentrations decrease in lab embryos from 24 to 72 hpf. Zebraﬁsh
(fed the usual laboratory diet) were spawned and embryos (n=4 groups of 10
embryos per time point) were harvested at 3, 24, 48 and 72 hpf. Individual values
(n=4) for the PUFA (DHA ○, linoleic acid (LA) ♢, eicosapentaenoic (EPA) □,
arachidonic acid (ARA) ▽, α-linolenic (ALA) ⩟) concentrations are shown at each
time point; note some values are overlap each other. Between 3 and 24 hpf there
were no statistically signiﬁcant changes in PUFA concentrations; subsequently, all
PUFA concentrations decreased with time and were different between each other
(ANOVA interaction Po0.0001, time Po0.0001, fatty acid Po0.0001). ANOVA
were calculated and Tukey paired comparisons carried out.
Fatty acid ANOVA 3 vs 24 h 24 vs 48 h 24 vs 72 h 48 vs 72 h
Tukey paired comparisons
DHA o0.0001 NS Po0.05 Po0.05 Po0.05
EPA o0.0001 NS NS Po0.05 Po0.05
ALA o0.0001 NS Po0.05 Po0.05 Po0.05
ARA o0.0001 Po0.05 NS Po0.05 Po0.05
LA o0.0001 NS Po0.05 Po0.05 Po0.05
Linear rates of disappearance were estimated using concentrations from 24 to
72 hpf. The rates of decrease were not different between α-linolenic and arachidonic
acid. Parameters of each of the lines generated were
DHA¼0.065Xþ21.77, R2¼0.913, Po0.0001;
eicosapentaenoic¼0.007Xþ1.506, R2¼0.7474, P¼0.0003;
α-linolenic¼0.002Xþ0.285, R2¼0.9272, Po0.0001;
arachidonic acid¼0.002Xþ0.882, R2¼0.6068, P¼0.0028;
linoleic acid¼0.01208Xþ1.932, R2¼0.9159, Po0.0001.
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Fig. 4. DHA concentrations decrease in E- but not in E+ embryos. Zebraﬁsh fed the E- or E+ deﬁned diets were spawned and embryos (n=4 groups of 10 embryos per time
point) were harvested at 3, 24, 48 and 72 hpf. α-Tocopherol concentrations in the embryos did not change between 3 and 24 hpf and did not change in E+ embryos up to 72
hpf. However, in E- embyros α-tocopherol concentrations decreased linearly between 24 and 72 h (α-tocopherol = -0.011 + 0.002, P=0.0005; E- vs E+ slope, P=0.0424). Of the
fatty acids, α-linolenic acid concentrations (ALA, C) were exceptional because they decreased in both E- and E+ between 3 and 24 hpf (P=0.0421); subsequently these
concentrations decreased similarly in both groups between 24 and 72 hpf (α-linolenic = -0.00075*X + 0.0733, R2=0.9141, P o 0.0001). In contrast, there were diet-
dependent (E+ vs E-) differences between 3 and 24 hpf in all of the other embryo PUFAs measured:
Comparisons between E and Eþ embryos, at 3 and 24 hpf
Graph: PUFA Diet time interaction Time Diet
A Linoleic acid NS NS P¼0.0002
B Arachidonic acid P¼0.0089 NS Po0.0001
D DHA NS NS Po0.0001
E Eicosapentaenoic P¼0.0042 P¼0.0033 Po0.0001
Linear rates of disappearance were estimated using concentrations from E and Eþ embryos; from 24 to 72 hpf, statistics shown are for the linear ﬁt; parameters for each of
the lines generated were
E linoleic acid¼0.022Xþ3.373, R2¼0.9039, Po0.0001;
Eþ linoleic acid¼0.016Xþ2.826, R2¼0.7593, P¼0.0005; E vs Eþ slope, P¼0.0491;
E arachidonic acid¼0.021Xþ4.643, R2¼0.898, Po0.0001;
Eþ arachidonic acid¼0.007Xþ3.425, R2¼0.4768, P¼0.0187; E vs Eþ slope, P¼0.008;
E DHA¼0.035Xþ11.29, R2¼0.7879, P¼0.0001;
Eþ DHA no signiﬁcant change; E vs Eþ slope, P¼0.0013;
E eicosapentaenoic¼0.0003Xþ0.0621, R2¼0.8328, Po0.0001; Eþ eicosapentaenoic¼ 0.0004Xþ0.099, R2¼0.5816, P¼0.0063; E vs Eþ slope, NS, P¼0.301.
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than in the E embryos (0.3 pg/h, Po0.0001). Interestingly, at
3 hpf E embryos contained 0.9 ng more DHA than did Eþ
embryos; DHA concentrations did not signiﬁcantly change in
either group between 3 and 24 hpf (Fig. 4D). Subsequently, E
embryos' DHA concentrations decreased at rate of 35 pg/h, while
Eþ embryos' DHA concentrations were unchanged (P¼0.0018 for
comparison of treatments). Finally, cholesterol concentrations did
not differ between E and Eþ embryos (data not shown).
α-Tocopherol deﬁciency increases HETE and docosanoid
concentrations
We have previously demonstrated that E embryos appear
normal at 36 hpf, but by 48 hpf, 50% of E embryos display
developmental defects [3]. We hypothesized that α-tocopherol is
needed to mediate the production of hydroxy-PUFAs, speciﬁcally
HETEs and HDHAs. Thus, we measured hydroxy-PUFAs at 36 hpf to
discern if altered production of these signaling molecules precedes
observable malformations in E embryos. Using authentic stan-
dards, we searched for 24 speciﬁc hydroxy-PUFAs. Of the 24 analytes,
only 5-HETE, 12-HETE, 7-HDHA, 10-HDHA, and 14-HDHA were
detectable in zebraﬁsh embryos fed our deﬁned diets. E embryos
had signiﬁcantly increased concentrations of 5-HETE and 7-HDHA
compared with Eþ embryos (Table 3). 12-HETE, 10-HDHA, 14-HDHA,
and 17-HDHA did not signiﬁcantly change in E embryos com-
pared with Eþ embryos.
Discussion
Based on our previous measurements of PUFAs in zebraﬁsh
embryos [35], this new LC–MS method allowed us several advan-
tages: (1) the number of embryos used per sample was reduced
10-fold, (2) PUFAs, α-tocopherol, and cholesterol were measured
in the same extract of embryos, (3) lengthy derivatizations of
PUFAs were avoided, and (4) absolute quantitation and recovery
for each individual PUFA was determined. This method should be
generally applicable to any situation where small sample sizes are
necessary.
α-Tocopherol deﬁciency increased the PUFA concentrations in
the early (3 hpf) zebraﬁsh embryo. A similar phenomenon was
observed in eggs from vitamin E deﬁcient chickens [42], suggest-
ing that the mother can increase the PUFA concentrations in eggs
in times of oxidative stress. α-Tocopherol deﬁciency also increased
the rate of decline of embryonic PUFA concentrations, as well as
increasing the hydroxy-PUFA concentrations from 24 to 72 hpf
(Fig. 4). In both E and Eþ embryos, as well as in the lab embryos,
PUFA concentrations declined, as development progressed. Mon-
roig et al. [43] previously reported that linoleic acid and α-
linolenic decline during zebraﬁsh development, whereas potential
products of linoleic acid and α-linolenic (sum of all other ω-6 and
ω-3 PUFAs, respectively) increase during embryogenesis relative to
total lipid content. We observed that α-tocopherol deﬁciency
increased the rate of decline in PUFAs, which could reﬂect
increased losses due to lipid peroxidation.
Notably, the highly peroxidizable DHA declined in E embryos,
but did not change in Eþ embryos. Concurrently, 7-HDHA was
elevated in E embryos compared with Eþ embryos. Radical-
mediated lipid peroxidation could produce the increase in 7-HDHA
measured in E embryos at 36 hpf. A limitation of this study is the
lack of chiral analysis of the monohydroxy fatty acids [44]. We have
presumed that these monohydroxy fatty acids are of enzymatic
origin; however, non-enzymatic autoxidation can play a signiﬁcant
role and α-tocopherol can act as an antioxidant in this process
[45,46]. However, not all HDHAs increased coordinately with α-
tocopherol deﬁciency, which is suggestive of a regulatory mechan-
ism controlling the peroxidation of DHA. LOX activity is mediated
by cellular hydroperoxide tone [36]. With α-tocopherol deﬁciency,
it is reasonable to assume that the cellular hydroperoxide tone
increases, and consequently, that LOX activity would increase and
account for the noted increase in HDHA. Interestingly, only 5-HETE
and 7-HDHA increased in E embryos, suggesting that 5-LOX was
speciﬁcally activated by vitamin E deﬁciency.
In summary, we demonstrated using novel methodologies that
α-tocopherol modulates PUFA and hydroxy-PUFA homeostasis
during vertebrate embryogenesis. Additionally, we have developed
highly sensitive methods for the analysis of fatty acids, cholesterol
and α-tocopherol in small biologic samples.
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